Awareness on Teratogenic Effects of Isotretinoin and Compliance with Precautionary Measures among Women of Childbearing Age in Makkah Province, Saudi Arabia

Table 2

Nature of isotretinoin treatment received by study participants (N = 766).

Study variable	%
Number of treatment courses with isotretinoin
One	68.5
Two	20.0
More than two	11.5
With doctor’s prescription
Yes	95.2
No	4.8
Year of treatment
2019	27.0
2014–2018	46.2
Before 2014	26.8
Reason for isotretinoin medication
Acne with oily skin and visible pores	52.1
Acne only	43.5
Perceived oily skin and visible pores without acne	2.7
Unrelated to acne	1.7
Daily maximum dose of isotretinoin
10–20 mg	45.2
30–40 mg	36.9
50–60 mg	4.8
≥70 mg	1.6
Unspecified	11.5
Duration of medication
<5 months	33.9
5–7 months	50.0
>7 months	16.1